Comparative in vitro study of six carbamazepine products

AAPS PharmSciTech

Volumn 9, Issue 2, 2008, Pages 357-365

  Mittapalli, Pavan Kumar ^a   Suresh, Bandari ^a   Hussaini, S S Q ^a   Rao, Yamasani Madhusudan ^a   Apte, Shashank ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

Carbamazepine; Dissolution; Drug release; Sodium lauryl sulfate

Indexed keywords

CARBAMAZEPINE; CARBATOL 200; MAZETOL 200; MEZAPIN; NEUROCARB 200; TEGRITAL 200; UNCLASSIFIED DRUG; ZEN 200; ANTICONVULSIVE AGENT; DODECYL SULFATE SODIUM; HYDROCHLORIC ACID;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISSOLUTION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG PACKAGING; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; TABLET; CHEMISTRY; COMPUTER GRAPHICS; COMPUTER PROGRAM; KINETICS; METHODOLOGY; PHARMACEUTICS; QUALITY CONTROL; SOLUBILITY; STANDARD;

ANTICONVULSANTS; CARBAMAZEPINE; CHEMISTRY, PHARMACEUTICAL; COMPUTER GRAPHICS; HYDROCHLORIC ACID; KINETICS; QUALITY CONTROL; SODIUM DODECYL SULFATE; SOFTWARE; SOLUBILITY; TABLETS; TECHNOLOGY, PHARMACEUTICAL;

EID: 51449097062     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9035-y     Document Type: Article

References (19)

1. A. Clarke. Isolation and identification of drugs. 2nd ed, The Pharmaceutical Press, London, UK, 1986.
2. L. E. Riad, K. K. Chan, and W. E. Wagner. Simultaneous first and zero order absorption of Carbamazepine tablets in humans. J. Pharm. Sci. 75: 897-900 (1986).
3. A. P. Aldenkamp, T. Rentmeester, J. Hulsman, et al. Pharmacokinetics and cognitive effects of Carbamazepine formulations with different dissolution rates. Eur. J. Clin. Pharm. 54: 184-192 (1998).
4. J. E. F. Reynolds, and A. B. Prasad. Martindale: The Extra Pharmacopoeia. 28th Edn., The Pharmaceutical Press, London, (1982).
5. M. Olling, T. T. Mensinga, D. M. Barends, C. Groen, O. A. Lake, and J. Meulenbelt. Bioavailability of Carbamazepine from four different products and the occurrence of side effects. Biopharm. Drug Dispos. 20: 19-28 (1999).
6. A. G. Davidson, F. Breslin, H. J. Lancashire, W. J. Mossop, and R. G. Alexander. A multinational survey of the quality of Carbamazepine tablets, Medicines testing laboratory, Edinburgh, UK, 1993.
7. W. L. Bell, I. L. Crawford, and G. K. Shiu. Reduced bioavailability of moisture-exposed Carbamazepine resulting in status epilepticus. Epilepsia. 34: 1102-1104 (1993).
8. M. C. Meyer, A. B. Straughn, E. J. Jarvi, G. C. Wood, F. R. Pelsor, and V. P. Shah. The bioinequivalence of Carbamazepine tablets with a history of clinical failures. Pharm. Res 9: 1612-1616 (1992).
9. J. T. Wang, G. K. Shiu, T. Ong-Chen, C. T. Vishwanathan, and J. P. Skelly. Effects of humidity and temperature on in vitro dissolution of Carbamazepine tablets. J Pharm Sci 83: 1002-1005 (1993).
10. P. N. Zakkinios, W. I. Li, J. K. Drennen, and R. A. Lodder. Spectrophotometric prediction of the dissolution rate of Carbamazepine tablets. Pharm. Res 8: 974-978 (1991).
11. H. Jung, R. C. Milan, M. E. Girard, F. Leon, and M. A. Montayo. Bioequivalence study of Carbamazepine tablets: In vitro/in vivo correlation. Int. J. Pharm 152: 37-44 (1997).
12. O. A. Lake, M. Olling, and D. M. Barends. In vitro/in vivo correlation of dissolution data of Carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers. Eur. J. Pharm. Biopharm 48: 13-19 (1999).
13. M. C. Meyer, A. B. Straughn, R. M. Mahatre, V. P. Shah, and R. L. Williams. The relative bioavailability and in vivo - in vitro correlation for four marketed Carbamazepine tablets. Pharm. Res 15: 1787-1791 (1998).
14. H. El-Zein, L. Riad, and A. A. El-Berry. Enhancement of Carbamazepine dissolution: In vitro and in vivo correlation. Int. J. Pharm. 168: 209-220 (1998).
15. H. Lee, S.-A. Park, and H. Sah. Surfactant effects upon dissolution patterns of Carbamazepine immediate release tablets. Arch. Pharm. Res. 28: 120-126 (2005).
16. N. Kaneniwa, O. Umezawaa, N. Watari, K. Kawatami, and H. Asami. Bioavailability and dissolution test of commercial Carbamazepine tablets. Yakugaku Zasshi 104: 83-90 (1984).
17. V. P. Shah, J. J. Konecny, R. L. Everett, B. McCullogh, A. C. Noorizadeh, and J. P. Skelly. In vitro dissolution profile of water insoluble drug dosage forms in the presence of surfactants. Pharm. Res 6: 612-618 (1989).
18. United States Pharmacopoeia, XXVI, United States, United States Pharmacopoeial Convention, Inc. 324-325 (2003).
19. S. Solvang, and P. Finholt. Effect of tablet processing and formulation factors on dissolution rate of the active ingredient in human gastric juice. J. Pharm. Sci 59: 49-52 (2006).